Global Infectious Diseases Molecular Diagnostics Market 2023 by Company, Regions, Type and Application, Forecast to 2029
The implications of current trends in molecular infectious diseases are moving towards high-throughput, simple, array-type technologies that will provide a wealth of data regarding types of organisms present in a sample and the virulence factors/resistance determinants that influence the severity of disease. As a result of these developments, infectious diseases will be more accurately and effectively treated.
According to our (Global Info Research) latest study, the global Infectious Diseases Molecular Diagnostics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Infectious Diseases Molecular Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Infectious Diseases Molecular Diagnostics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Infectious Diseases Molecular Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Infectious Diseases Molecular Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Infectious Diseases Molecular Diagnostics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Infectious Diseases Molecular Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Infectious Diseases Molecular Diagnostics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Qiagen, Illumina, Abbott and Hologic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Infectious Diseases Molecular Diagnostics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Infectious Diseases Molecular Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infectious Diseases Molecular Diagnostics, with revenue, gross margin and global market share of Infectious Diseases Molecular Diagnostics from 2018 to 2023.
Chapter 3, the Infectious Diseases Molecular Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Infectious Diseases Molecular Diagnostics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Infectious Diseases Molecular Diagnostics.
Chapter 13, to describe Infectious Diseases Molecular Diagnostics research findings and conclusion.
According to our (Global Info Research) latest study, the global Infectious Diseases Molecular Diagnostics market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
This report is a detailed and comprehensive analysis for global Infectious Diseases Molecular Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Infectious Diseases Molecular Diagnostics market size and forecasts, in consumption value ($ Million), 2018-2029
Global Infectious Diseases Molecular Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Infectious Diseases Molecular Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Infectious Diseases Molecular Diagnostics market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Infectious Diseases Molecular Diagnostics
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Infectious Diseases Molecular Diagnostics market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche, Qiagen, Illumina, Abbott and Hologic, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Infectious Diseases Molecular Diagnostics market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Polymerase Chain Reaction PCR
- Molecular Hybridization
- Biochip
- Others
- Hospital
- Third-party Testing Agency
- Others
- Roche
- Qiagen
- Illumina
- Abbott
- Hologic
- BioMerieux
- Danaher (Cepheid)
- Myriad Genetics
- DAAN Gene
- Agilent
- Genomic Health
- BD
- Foundation Medicine
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Infectious Diseases Molecular Diagnostics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Infectious Diseases Molecular Diagnostics, with revenue, gross margin and global market share of Infectious Diseases Molecular Diagnostics from 2018 to 2023.
Chapter 3, the Infectious Diseases Molecular Diagnostics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Infectious Diseases Molecular Diagnostics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Infectious Diseases Molecular Diagnostics.
Chapter 13, to describe Infectious Diseases Molecular Diagnostics research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Infectious Diseases Molecular Diagnostics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Infectious Diseases Molecular Diagnostics by Type
1.3.1 Overview: Global Infectious Diseases Molecular Diagnostics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Type in 2022
1.3.3 Polymerase Chain Reaction PCR
1.3.4 Molecular Hybridization
1.3.5 Biochip
1.3.6 Others
1.4 Global Infectious Diseases Molecular Diagnostics Market by Application
1.4.1 Overview: Global Infectious Diseases Molecular Diagnostics Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Third-party Testing Agency
1.4.4 Others
1.5 Global Infectious Diseases Molecular Diagnostics Market Size & Forecast
1.6 Global Infectious Diseases Molecular Diagnostics Market Size and Forecast by Region
1.6.1 Global Infectious Diseases Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Infectious Diseases Molecular Diagnostics Market Size by Region, (2018-2029)
1.6.3 North America Infectious Diseases Molecular Diagnostics Market Size and Prospect (2018-2029)
1.6.4 Europe Infectious Diseases Molecular Diagnostics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size and Prospect (2018-2029)
1.6.6 South America Infectious Diseases Molecular Diagnostics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Infectious Diseases Molecular Diagnostics Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Infectious Diseases Molecular Diagnostics Product and Solutions
2.1.4 Roche Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments and Future Plans
2.2 Qiagen
2.2.1 Qiagen Details
2.2.2 Qiagen Major Business
2.2.3 Qiagen Infectious Diseases Molecular Diagnostics Product and Solutions
2.2.4 Qiagen Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Qiagen Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Infectious Diseases Molecular Diagnostics Product and Solutions
2.3.4 Illumina Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Infectious Diseases Molecular Diagnostics Product and Solutions
2.4.4 Abbott Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Abbott Recent Developments and Future Plans
2.5 Hologic
2.5.1 Hologic Details
2.5.2 Hologic Major Business
2.5.3 Hologic Infectious Diseases Molecular Diagnostics Product and Solutions
2.5.4 Hologic Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hologic Recent Developments and Future Plans
2.6 BioMerieux
2.6.1 BioMerieux Details
2.6.2 BioMerieux Major Business
2.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Product and Solutions
2.6.4 BioMerieux Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 BioMerieux Recent Developments and Future Plans
2.7 Danaher (Cepheid)
2.7.1 Danaher (Cepheid) Details
2.7.2 Danaher (Cepheid) Major Business
2.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product and Solutions
2.7.4 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Danaher (Cepheid) Recent Developments and Future Plans
2.8 Myriad Genetics
2.8.1 Myriad Genetics Details
2.8.2 Myriad Genetics Major Business
2.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Product and Solutions
2.8.4 Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Myriad Genetics Recent Developments and Future Plans
2.9 DAAN Gene
2.9.1 DAAN Gene Details
2.9.2 DAAN Gene Major Business
2.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Product and Solutions
2.9.4 DAAN Gene Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 DAAN Gene Recent Developments and Future Plans
2.10 Agilent
2.10.1 Agilent Details
2.10.2 Agilent Major Business
2.10.3 Agilent Infectious Diseases Molecular Diagnostics Product and Solutions
2.10.4 Agilent Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Agilent Recent Developments and Future Plans
2.11 Genomic Health
2.11.1 Genomic Health Details
2.11.2 Genomic Health Major Business
2.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Product and Solutions
2.11.4 Genomic Health Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Genomic Health Recent Developments and Future Plans
2.12 BD
2.12.1 BD Details
2.12.2 BD Major Business
2.12.3 BD Infectious Diseases Molecular Diagnostics Product and Solutions
2.12.4 BD Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 BD Recent Developments and Future Plans
2.13 Foundation Medicine
2.13.1 Foundation Medicine Details
2.13.2 Foundation Medicine Major Business
2.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Product and Solutions
2.13.4 Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Foundation Medicine Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Infectious Diseases Molecular Diagnostics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Infectious Diseases Molecular Diagnostics by Company Revenue
3.2.2 Top 3 Infectious Diseases Molecular Diagnostics Players Market Share in 2022
3.2.3 Top 6 Infectious Diseases Molecular Diagnostics Players Market Share in 2022
3.3 Infectious Diseases Molecular Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Infectious Diseases Molecular Diagnostics Market: Region Footprint
3.3.2 Infectious Diseases Molecular Diagnostics Market: Company Product Type Footprint
3.3.3 Infectious Diseases Molecular Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Infectious Diseases Molecular Diagnostics Consumption Value and Market Share by Type (2018-2023)
4.2 Global Infectious Diseases Molecular Diagnostics Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Application (2018-2023)
5.2 Global Infectious Diseases Molecular Diagnostics Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2029)
6.2 North America Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2029)
6.3 North America Infectious Diseases Molecular Diagnostics Market Size by Country
6.3.1 North America Infectious Diseases Molecular Diagnostics Consumption Value by Country (2018-2029)
6.3.2 United States Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
6.3.3 Canada Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
6.3.4 Mexico Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2029)
7.2 Europe Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2029)
7.3 Europe Infectious Diseases Molecular Diagnostics Market Size by Country
7.3.1 Europe Infectious Diseases Molecular Diagnostics Consumption Value by Country (2018-2029)
7.3.2 Germany Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
7.3.3 France Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
7.3.5 Russia Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
7.3.6 Italy Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size by Region
8.3.1 Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value by Region (2018-2029)
8.3.2 China Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
8.3.3 Japan Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
8.3.4 South Korea Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
8.3.5 India Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
8.3.7 Australia Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2029)
9.2 South America Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2029)
9.3 South America Infectious Diseases Molecular Diagnostics Market Size by Country
9.3.1 South America Infectious Diseases Molecular Diagnostics Consumption Value by Country (2018-2029)
9.3.2 Brazil Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
9.3.3 Argentina Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Country
10.3.1 Middle East & Africa Infectious Diseases Molecular Diagnostics Consumption Value by Country (2018-2029)
10.3.2 Turkey Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
10.3.4 UAE Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Infectious Diseases Molecular Diagnostics Market Drivers
11.2 Infectious Diseases Molecular Diagnostics Market Restraints
11.3 Infectious Diseases Molecular Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Infectious Diseases Molecular Diagnostics Industry Chain
12.2 Infectious Diseases Molecular Diagnostics Upstream Analysis
12.3 Infectious Diseases Molecular Diagnostics Midstream Analysis
12.4 Infectious Diseases Molecular Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Infectious Diseases Molecular Diagnostics
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Infectious Diseases Molecular Diagnostics by Type
1.3.1 Overview: Global Infectious Diseases Molecular Diagnostics Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Type in 2022
1.3.3 Polymerase Chain Reaction PCR
1.3.4 Molecular Hybridization
1.3.5 Biochip
1.3.6 Others
1.4 Global Infectious Diseases Molecular Diagnostics Market by Application
1.4.1 Overview: Global Infectious Diseases Molecular Diagnostics Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Third-party Testing Agency
1.4.4 Others
1.5 Global Infectious Diseases Molecular Diagnostics Market Size & Forecast
1.6 Global Infectious Diseases Molecular Diagnostics Market Size and Forecast by Region
1.6.1 Global Infectious Diseases Molecular Diagnostics Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Infectious Diseases Molecular Diagnostics Market Size by Region, (2018-2029)
1.6.3 North America Infectious Diseases Molecular Diagnostics Market Size and Prospect (2018-2029)
1.6.4 Europe Infectious Diseases Molecular Diagnostics Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size and Prospect (2018-2029)
1.6.6 South America Infectious Diseases Molecular Diagnostics Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Infectious Diseases Molecular Diagnostics Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Infectious Diseases Molecular Diagnostics Product and Solutions
2.1.4 Roche Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Recent Developments and Future Plans
2.2 Qiagen
2.2.1 Qiagen Details
2.2.2 Qiagen Major Business
2.2.3 Qiagen Infectious Diseases Molecular Diagnostics Product and Solutions
2.2.4 Qiagen Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Qiagen Recent Developments and Future Plans
2.3 Illumina
2.3.1 Illumina Details
2.3.2 Illumina Major Business
2.3.3 Illumina Infectious Diseases Molecular Diagnostics Product and Solutions
2.3.4 Illumina Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Illumina Recent Developments and Future Plans
2.4 Abbott
2.4.1 Abbott Details
2.4.2 Abbott Major Business
2.4.3 Abbott Infectious Diseases Molecular Diagnostics Product and Solutions
2.4.4 Abbott Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Abbott Recent Developments and Future Plans
2.5 Hologic
2.5.1 Hologic Details
2.5.2 Hologic Major Business
2.5.3 Hologic Infectious Diseases Molecular Diagnostics Product and Solutions
2.5.4 Hologic Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Hologic Recent Developments and Future Plans
2.6 BioMerieux
2.6.1 BioMerieux Details
2.6.2 BioMerieux Major Business
2.6.3 BioMerieux Infectious Diseases Molecular Diagnostics Product and Solutions
2.6.4 BioMerieux Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 BioMerieux Recent Developments and Future Plans
2.7 Danaher (Cepheid)
2.7.1 Danaher (Cepheid) Details
2.7.2 Danaher (Cepheid) Major Business
2.7.3 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product and Solutions
2.7.4 Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Danaher (Cepheid) Recent Developments and Future Plans
2.8 Myriad Genetics
2.8.1 Myriad Genetics Details
2.8.2 Myriad Genetics Major Business
2.8.3 Myriad Genetics Infectious Diseases Molecular Diagnostics Product and Solutions
2.8.4 Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Myriad Genetics Recent Developments and Future Plans
2.9 DAAN Gene
2.9.1 DAAN Gene Details
2.9.2 DAAN Gene Major Business
2.9.3 DAAN Gene Infectious Diseases Molecular Diagnostics Product and Solutions
2.9.4 DAAN Gene Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 DAAN Gene Recent Developments and Future Plans
2.10 Agilent
2.10.1 Agilent Details
2.10.2 Agilent Major Business
2.10.3 Agilent Infectious Diseases Molecular Diagnostics Product and Solutions
2.10.4 Agilent Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Agilent Recent Developments and Future Plans
2.11 Genomic Health
2.11.1 Genomic Health Details
2.11.2 Genomic Health Major Business
2.11.3 Genomic Health Infectious Diseases Molecular Diagnostics Product and Solutions
2.11.4 Genomic Health Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Genomic Health Recent Developments and Future Plans
2.12 BD
2.12.1 BD Details
2.12.2 BD Major Business
2.12.3 BD Infectious Diseases Molecular Diagnostics Product and Solutions
2.12.4 BD Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 BD Recent Developments and Future Plans
2.13 Foundation Medicine
2.13.1 Foundation Medicine Details
2.13.2 Foundation Medicine Major Business
2.13.3 Foundation Medicine Infectious Diseases Molecular Diagnostics Product and Solutions
2.13.4 Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Foundation Medicine Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Infectious Diseases Molecular Diagnostics Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Infectious Diseases Molecular Diagnostics by Company Revenue
3.2.2 Top 3 Infectious Diseases Molecular Diagnostics Players Market Share in 2022
3.2.3 Top 6 Infectious Diseases Molecular Diagnostics Players Market Share in 2022
3.3 Infectious Diseases Molecular Diagnostics Market: Overall Company Footprint Analysis
3.3.1 Infectious Diseases Molecular Diagnostics Market: Region Footprint
3.3.2 Infectious Diseases Molecular Diagnostics Market: Company Product Type Footprint
3.3.3 Infectious Diseases Molecular Diagnostics Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Infectious Diseases Molecular Diagnostics Consumption Value and Market Share by Type (2018-2023)
4.2 Global Infectious Diseases Molecular Diagnostics Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Application (2018-2023)
5.2 Global Infectious Diseases Molecular Diagnostics Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2029)
6.2 North America Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2029)
6.3 North America Infectious Diseases Molecular Diagnostics Market Size by Country
6.3.1 North America Infectious Diseases Molecular Diagnostics Consumption Value by Country (2018-2029)
6.3.2 United States Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
6.3.3 Canada Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
6.3.4 Mexico Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2029)
7.2 Europe Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2029)
7.3 Europe Infectious Diseases Molecular Diagnostics Market Size by Country
7.3.1 Europe Infectious Diseases Molecular Diagnostics Consumption Value by Country (2018-2029)
7.3.2 Germany Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
7.3.3 France Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
7.3.5 Russia Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
7.3.6 Italy Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Infectious Diseases Molecular Diagnostics Market Size by Region
8.3.1 Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value by Region (2018-2029)
8.3.2 China Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
8.3.3 Japan Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
8.3.4 South Korea Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
8.3.5 India Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
8.3.7 Australia Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2029)
9.2 South America Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2029)
9.3 South America Infectious Diseases Molecular Diagnostics Market Size by Country
9.3.1 South America Infectious Diseases Molecular Diagnostics Consumption Value by Country (2018-2029)
9.3.2 Brazil Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
9.3.3 Argentina Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Infectious Diseases Molecular Diagnostics Market Size by Country
10.3.1 Middle East & Africa Infectious Diseases Molecular Diagnostics Consumption Value by Country (2018-2029)
10.3.2 Turkey Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
10.3.4 UAE Infectious Diseases Molecular Diagnostics Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Infectious Diseases Molecular Diagnostics Market Drivers
11.2 Infectious Diseases Molecular Diagnostics Market Restraints
11.3 Infectious Diseases Molecular Diagnostics Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Infectious Diseases Molecular Diagnostics Industry Chain
12.2 Infectious Diseases Molecular Diagnostics Upstream Analysis
12.3 Infectious Diseases Molecular Diagnostics Midstream Analysis
12.4 Infectious Diseases Molecular Diagnostics Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Infectious Diseases Molecular Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Infectious Diseases Molecular Diagnostics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Infectious Diseases Molecular Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Infectious Diseases Molecular Diagnostics Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Infectious Diseases Molecular Diagnostics Product and Solutions
Table 8. Roche Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche Recent Developments and Future Plans
Table 10. Qiagen Company Information, Head Office, and Major Competitors
Table 11. Qiagen Major Business
Table 12. Qiagen Infectious Diseases Molecular Diagnostics Product and Solutions
Table 13. Qiagen Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Qiagen Recent Developments and Future Plans
Table 15. Illumina Company Information, Head Office, and Major Competitors
Table 16. Illumina Major Business
Table 17. Illumina Infectious Diseases Molecular Diagnostics Product and Solutions
Table 18. Illumina Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Illumina Recent Developments and Future Plans
Table 20. Abbott Company Information, Head Office, and Major Competitors
Table 21. Abbott Major Business
Table 22. Abbott Infectious Diseases Molecular Diagnostics Product and Solutions
Table 23. Abbott Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Abbott Recent Developments and Future Plans
Table 25. Hologic Company Information, Head Office, and Major Competitors
Table 26. Hologic Major Business
Table 27. Hologic Infectious Diseases Molecular Diagnostics Product and Solutions
Table 28. Hologic Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Hologic Recent Developments and Future Plans
Table 30. BioMerieux Company Information, Head Office, and Major Competitors
Table 31. BioMerieux Major Business
Table 32. BioMerieux Infectious Diseases Molecular Diagnostics Product and Solutions
Table 33. BioMerieux Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. BioMerieux Recent Developments and Future Plans
Table 35. Danaher (Cepheid) Company Information, Head Office, and Major Competitors
Table 36. Danaher (Cepheid) Major Business
Table 37. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product and Solutions
Table 38. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Danaher (Cepheid) Recent Developments and Future Plans
Table 40. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 41. Myriad Genetics Major Business
Table 42. Myriad Genetics Infectious Diseases Molecular Diagnostics Product and Solutions
Table 43. Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Myriad Genetics Recent Developments and Future Plans
Table 45. DAAN Gene Company Information, Head Office, and Major Competitors
Table 46. DAAN Gene Major Business
Table 47. DAAN Gene Infectious Diseases Molecular Diagnostics Product and Solutions
Table 48. DAAN Gene Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. DAAN Gene Recent Developments and Future Plans
Table 50. Agilent Company Information, Head Office, and Major Competitors
Table 51. Agilent Major Business
Table 52. Agilent Infectious Diseases Molecular Diagnostics Product and Solutions
Table 53. Agilent Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Agilent Recent Developments and Future Plans
Table 55. Genomic Health Company Information, Head Office, and Major Competitors
Table 56. Genomic Health Major Business
Table 57. Genomic Health Infectious Diseases Molecular Diagnostics Product and Solutions
Table 58. Genomic Health Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Genomic Health Recent Developments and Future Plans
Table 60. BD Company Information, Head Office, and Major Competitors
Table 61. BD Major Business
Table 62. BD Infectious Diseases Molecular Diagnostics Product and Solutions
Table 63. BD Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. BD Recent Developments and Future Plans
Table 65. Foundation Medicine Company Information, Head Office, and Major Competitors
Table 66. Foundation Medicine Major Business
Table 67. Foundation Medicine Infectious Diseases Molecular Diagnostics Product and Solutions
Table 68. Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Foundation Medicine Recent Developments and Future Plans
Table 70. Global Infectious Diseases Molecular Diagnostics Revenue (USD Million) by Players (2018-2023)
Table 71. Global Infectious Diseases Molecular Diagnostics Revenue Share by Players (2018-2023)
Table 72. Breakdown of Infectious Diseases Molecular Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Infectious Diseases Molecular Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Infectious Diseases Molecular Diagnostics Players
Table 75. Infectious Diseases Molecular Diagnostics Market: Company Product Type Footprint
Table 76. Infectious Diseases Molecular Diagnostics Market: Company Product Application Footprint
Table 77. Infectious Diseases Molecular Diagnostics New Market Entrants and Barriers to Market Entry
Table 78. Infectious Diseases Molecular Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Infectious Diseases Molecular Diagnostics Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Infectious Diseases Molecular Diagnostics Consumption Value Share by Type (2018-2023)
Table 81. Global Infectious Diseases Molecular Diagnostics Consumption Value Forecast by Type (2024-2029)
Table 82. Global Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2023)
Table 83. Global Infectious Diseases Molecular Diagnostics Consumption Value Forecast by Application (2024-2029)
Table 84. North America Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Infectious Diseases Molecular Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Infectious Diseases Molecular Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Infectious Diseases Molecular Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Infectious Diseases Molecular Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Infectious Diseases Molecular Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Infectious Diseases Molecular Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Infectious Diseases Molecular Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Infectious Diseases Molecular Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Infectious Diseases Molecular Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Infectious Diseases Molecular Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Infectious Diseases Molecular Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Infectious Diseases Molecular Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Infectious Diseases Molecular Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Infectious Diseases Molecular Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Infectious Diseases Molecular Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Infectious Diseases Molecular Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Infectious Diseases Molecular Diagnostics Raw Material
Table 115. Key Suppliers of Infectious Diseases Molecular Diagnostics Raw Materials
Table 1. Global Infectious Diseases Molecular Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Infectious Diseases Molecular Diagnostics Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Infectious Diseases Molecular Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Infectious Diseases Molecular Diagnostics Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Infectious Diseases Molecular Diagnostics Product and Solutions
Table 8. Roche Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Roche Recent Developments and Future Plans
Table 10. Qiagen Company Information, Head Office, and Major Competitors
Table 11. Qiagen Major Business
Table 12. Qiagen Infectious Diseases Molecular Diagnostics Product and Solutions
Table 13. Qiagen Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Qiagen Recent Developments and Future Plans
Table 15. Illumina Company Information, Head Office, and Major Competitors
Table 16. Illumina Major Business
Table 17. Illumina Infectious Diseases Molecular Diagnostics Product and Solutions
Table 18. Illumina Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Illumina Recent Developments and Future Plans
Table 20. Abbott Company Information, Head Office, and Major Competitors
Table 21. Abbott Major Business
Table 22. Abbott Infectious Diseases Molecular Diagnostics Product and Solutions
Table 23. Abbott Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Abbott Recent Developments and Future Plans
Table 25. Hologic Company Information, Head Office, and Major Competitors
Table 26. Hologic Major Business
Table 27. Hologic Infectious Diseases Molecular Diagnostics Product and Solutions
Table 28. Hologic Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Hologic Recent Developments and Future Plans
Table 30. BioMerieux Company Information, Head Office, and Major Competitors
Table 31. BioMerieux Major Business
Table 32. BioMerieux Infectious Diseases Molecular Diagnostics Product and Solutions
Table 33. BioMerieux Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. BioMerieux Recent Developments and Future Plans
Table 35. Danaher (Cepheid) Company Information, Head Office, and Major Competitors
Table 36. Danaher (Cepheid) Major Business
Table 37. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Product and Solutions
Table 38. Danaher (Cepheid) Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Danaher (Cepheid) Recent Developments and Future Plans
Table 40. Myriad Genetics Company Information, Head Office, and Major Competitors
Table 41. Myriad Genetics Major Business
Table 42. Myriad Genetics Infectious Diseases Molecular Diagnostics Product and Solutions
Table 43. Myriad Genetics Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Myriad Genetics Recent Developments and Future Plans
Table 45. DAAN Gene Company Information, Head Office, and Major Competitors
Table 46. DAAN Gene Major Business
Table 47. DAAN Gene Infectious Diseases Molecular Diagnostics Product and Solutions
Table 48. DAAN Gene Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. DAAN Gene Recent Developments and Future Plans
Table 50. Agilent Company Information, Head Office, and Major Competitors
Table 51. Agilent Major Business
Table 52. Agilent Infectious Diseases Molecular Diagnostics Product and Solutions
Table 53. Agilent Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Agilent Recent Developments and Future Plans
Table 55. Genomic Health Company Information, Head Office, and Major Competitors
Table 56. Genomic Health Major Business
Table 57. Genomic Health Infectious Diseases Molecular Diagnostics Product and Solutions
Table 58. Genomic Health Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Genomic Health Recent Developments and Future Plans
Table 60. BD Company Information, Head Office, and Major Competitors
Table 61. BD Major Business
Table 62. BD Infectious Diseases Molecular Diagnostics Product and Solutions
Table 63. BD Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. BD Recent Developments and Future Plans
Table 65. Foundation Medicine Company Information, Head Office, and Major Competitors
Table 66. Foundation Medicine Major Business
Table 67. Foundation Medicine Infectious Diseases Molecular Diagnostics Product and Solutions
Table 68. Foundation Medicine Infectious Diseases Molecular Diagnostics Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. Foundation Medicine Recent Developments and Future Plans
Table 70. Global Infectious Diseases Molecular Diagnostics Revenue (USD Million) by Players (2018-2023)
Table 71. Global Infectious Diseases Molecular Diagnostics Revenue Share by Players (2018-2023)
Table 72. Breakdown of Infectious Diseases Molecular Diagnostics by Company Type (Tier 1, Tier 2, and Tier 3)
Table 73. Market Position of Players in Infectious Diseases Molecular Diagnostics, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 74. Head Office of Key Infectious Diseases Molecular Diagnostics Players
Table 75. Infectious Diseases Molecular Diagnostics Market: Company Product Type Footprint
Table 76. Infectious Diseases Molecular Diagnostics Market: Company Product Application Footprint
Table 77. Infectious Diseases Molecular Diagnostics New Market Entrants and Barriers to Market Entry
Table 78. Infectious Diseases Molecular Diagnostics Mergers, Acquisition, Agreements, and Collaborations
Table 79. Global Infectious Diseases Molecular Diagnostics Consumption Value (USD Million) by Type (2018-2023)
Table 80. Global Infectious Diseases Molecular Diagnostics Consumption Value Share by Type (2018-2023)
Table 81. Global Infectious Diseases Molecular Diagnostics Consumption Value Forecast by Type (2024-2029)
Table 82. Global Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2023)
Table 83. Global Infectious Diseases Molecular Diagnostics Consumption Value Forecast by Application (2024-2029)
Table 84. North America Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 85. North America Infectious Diseases Molecular Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 86. North America Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 87. North America Infectious Diseases Molecular Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 88. North America Infectious Diseases Molecular Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 89. North America Infectious Diseases Molecular Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 90. Europe Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 91. Europe Infectious Diseases Molecular Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 92. Europe Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 93. Europe Infectious Diseases Molecular Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 94. Europe Infectious Diseases Molecular Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 95. Europe Infectious Diseases Molecular Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 96. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 97. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 98. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 99. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 100. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value by Region (2018-2023) & (USD Million)
Table 101. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value by Region (2024-2029) & (USD Million)
Table 102. South America Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 103. South America Infectious Diseases Molecular Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 104. South America Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 105. South America Infectious Diseases Molecular Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 106. South America Infectious Diseases Molecular Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 107. South America Infectious Diseases Molecular Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 108. Middle East & Africa Infectious Diseases Molecular Diagnostics Consumption Value by Type (2018-2023) & (USD Million)
Table 109. Middle East & Africa Infectious Diseases Molecular Diagnostics Consumption Value by Type (2024-2029) & (USD Million)
Table 110. Middle East & Africa Infectious Diseases Molecular Diagnostics Consumption Value by Application (2018-2023) & (USD Million)
Table 111. Middle East & Africa Infectious Diseases Molecular Diagnostics Consumption Value by Application (2024-2029) & (USD Million)
Table 112. Middle East & Africa Infectious Diseases Molecular Diagnostics Consumption Value by Country (2018-2023) & (USD Million)
Table 113. Middle East & Africa Infectious Diseases Molecular Diagnostics Consumption Value by Country (2024-2029) & (USD Million)
Table 114. Infectious Diseases Molecular Diagnostics Raw Material
Table 115. Key Suppliers of Infectious Diseases Molecular Diagnostics Raw Materials
LIST OF FIGURES
Figure 1. Infectious Diseases Molecular Diagnostics Picture
Figure 2. Global Infectious Diseases Molecular Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Type in 2022
Figure 4. Polymerase Chain Reaction PCR
Figure 5. Molecular Hybridization
Figure 6. Biochip
Figure 7. Others
Figure 8. Global Infectious Diseases Molecular Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Application in 2022
Figure 10. Hospital Picture
Figure 11. Third-party Testing Agency Picture
Figure 12. Others Picture
Figure 13. Global Infectious Diseases Molecular Diagnostics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Infectious Diseases Molecular Diagnostics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Infectious Diseases Molecular Diagnostics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Region in 2022
Figure 18. North America Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Infectious Diseases Molecular Diagnostics Revenue Share by Players in 2022
Figure 24. Infectious Diseases Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Infectious Diseases Molecular Diagnostics Market Share in 2022
Figure 26. Global Top 6 Players Infectious Diseases Molecular Diagnostics Market Share in 2022
Figure 27. Global Infectious Diseases Molecular Diagnostics Consumption Value Share by Type (2018-2023)
Figure 28. Global Infectious Diseases Molecular Diagnostics Market Share Forecast by Type (2024-2029)
Figure 29. Global Infectious Diseases Molecular Diagnostics Consumption Value Share by Application (2018-2023)
Figure 30. Global Infectious Diseases Molecular Diagnostics Market Share Forecast by Application (2024-2029)
Figure 31. North America Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 41. France Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Region (2018-2029)
Figure 48. China Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 51. India Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 65. Infectious Diseases Molecular Diagnostics Market Drivers
Figure 66. Infectious Diseases Molecular Diagnostics Market Restraints
Figure 67. Infectious Diseases Molecular Diagnostics Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Infectious Diseases Molecular Diagnostics in 2022
Figure 70. Manufacturing Process Analysis of Infectious Diseases Molecular Diagnostics
Figure 71. Infectious Diseases Molecular Diagnostics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Infectious Diseases Molecular Diagnostics Picture
Figure 2. Global Infectious Diseases Molecular Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Type in 2022
Figure 4. Polymerase Chain Reaction PCR
Figure 5. Molecular Hybridization
Figure 6. Biochip
Figure 7. Others
Figure 8. Global Infectious Diseases Molecular Diagnostics Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Application in 2022
Figure 10. Hospital Picture
Figure 11. Third-party Testing Agency Picture
Figure 12. Others Picture
Figure 13. Global Infectious Diseases Molecular Diagnostics Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Infectious Diseases Molecular Diagnostics Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Infectious Diseases Molecular Diagnostics Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Region in 2022
Figure 18. North America Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Infectious Diseases Molecular Diagnostics Revenue Share by Players in 2022
Figure 24. Infectious Diseases Molecular Diagnostics Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Infectious Diseases Molecular Diagnostics Market Share in 2022
Figure 26. Global Top 6 Players Infectious Diseases Molecular Diagnostics Market Share in 2022
Figure 27. Global Infectious Diseases Molecular Diagnostics Consumption Value Share by Type (2018-2023)
Figure 28. Global Infectious Diseases Molecular Diagnostics Market Share Forecast by Type (2024-2029)
Figure 29. Global Infectious Diseases Molecular Diagnostics Consumption Value Share by Application (2018-2023)
Figure 30. Global Infectious Diseases Molecular Diagnostics Market Share Forecast by Application (2024-2029)
Figure 31. North America Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 41. France Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Region (2018-2029)
Figure 48. China Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 51. India Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Infectious Diseases Molecular Diagnostics Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Infectious Diseases Molecular Diagnostics Consumption Value (2018-2029) & (USD Million)
Figure 65. Infectious Diseases Molecular Diagnostics Market Drivers
Figure 66. Infectious Diseases Molecular Diagnostics Market Restraints
Figure 67. Infectious Diseases Molecular Diagnostics Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Infectious Diseases Molecular Diagnostics in 2022
Figure 70. Manufacturing Process Analysis of Infectious Diseases Molecular Diagnostics
Figure 71. Infectious Diseases Molecular Diagnostics Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
